Want to Invest in Biotech? This ETF Is Crushing Biogen and Gilead
There's a thrill associated with investing in biotech. Many companies are developing new drugs that could dramatically change how diseases are treated. Some are even working on potential cures for certain diseases. Seemingly every week brings news with the potential to send some stocks soaring (and sometimes sinking, too).
If you want to invest in biotech stocks, you have lots of options. These options include some large, highly successful companies such as Biogen (NASDAQ: BIIB) and Gilead Sciences (NASDAQ: GILD). These two big biotechs have together reshaped the landscape for treating several diseases.
If you're looking to make strong returns investing in biotech, there's another alternative that you might not have heard much about: biotech-focused exchange-traded fund SPDR S&P Biotech ETF (NYSEMKT: XBI). This ETF is absolutely crushing Biogen and Gilead.
Source Fool.com
